TED Member States· European UniontenderOpen · 27 Oct 2026
Supply of Medicines – Active Substance Rozanolixizumab – ATC L04AL02
Fakultní Thomayerova nemocnice
Deadline 27 Oct 2026Deadline27 Oct 2026
Estimated valueCZK 129,980,502
CPV category33652300
Published25 Sep 2026
Reference664356-2026
Notice summary
The subject of the public procurement is the ongoing supply of the medicinal product containing the active substance rozanolixizumab – ATC L04AL02. Form 140MG/ML INJ SOL 1X2ML, unit 1X2ML, quantity 600. Form 140MG/ML INJ SOL 1X3ML, unit 1X3ML, quantity 100.
Is this worth bidding on?
Tender Radar scores every tender against your company profile, surfaces the matching services, and flags the ones worth your time — across Europe and beyond. Sign in to see the relevance match and full AI analysis for this opportunity.